Research ArticleArticle
Six and 12 Weeks Treatment Response Predicts Continuation of Tumor Necrosis Factor Blockade in Rheumatoid Arthritis: An Observational Cohort Study from Southern Sweden
ANDERS GÜLFE, LARS ERIK KRISTENSEN and PIERRE GEBOREK
The Journal of Rheumatology March 2009, 36 (3) 517-521; DOI: https://doi.org/10.3899/jrheum.080509
ANDERS GÜLFE
LARS ERIK KRISTENSEN
REFERENCES
- 1.↵
- Hyrich KL,
- Watson KD,
- Silman AJ,
- Symmons DP
- 2.↵
- Kristensen LE,
- Kapetanovic MC,
- Gulfe A,
- Soderlin M,
- Saxne T,
- Geborek P
- 3.↵
- Geborek P,
- Saxne T
- 4.↵
- Geborek P,
- Nitelius E,
- Noltorp S,
- et al
- 5.↵
- 6.↵
- van Gestel AM,
- Prevoo ML,
- van ‘t Hof MA,
- van Rijswijk MH,
- van de Putte LB,
- van Riel PL
- 7.↵
- Smolen JS,
- Breedveld FC,
- Schiff MH,
- et al
- 8.↵
- 9.↵
- Prevoo ML,
- van ‘t Hof MA,
- Kuper HH,
- van Leeuwen MA,
- van de Putte LB,
- van Riel PL
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- Zink A,
- Listing J,
- Kary S,
- et al
- 15.↵
- Gulfe A,
- Geborek P,
- Saxne T
- 16.↵Guidelines for Pharmacotherapy of Rheumatoid Arthritis. In: The Swedish Society for Rheumatology; 2004 [Swedish]. Internet. Accessed Dec 19, 2008. Available from: http://www.musconline.org/html/srf/images/documents/riktra04/riktrakort.pdf
- 17.↵
- van der Kooij SM,
- Goekoop-Ruiterman YP,
- de Vries-Bouwstra JK,
- et al
- 18.↵
- 19.↵
In this issue
The Journal of Rheumatology
Vol. 36, Issue 3
1 Mar 2009
Six and 12 Weeks Treatment Response Predicts Continuation of Tumor Necrosis Factor Blockade in Rheumatoid Arthritis: An Observational Cohort Study from Southern Sweden
ANDERS GÜLFE, LARS ERIK KRISTENSEN, PIERRE GEBOREK
The Journal of Rheumatology Mar 2009, 36 (3) 517-521; DOI: 10.3899/jrheum.080509